111, Inc. Regains Compliance with NASDAQ Requirement
SHANGHAI, Feb. 11, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and...
Breakthrough Silane-Free Silicon Anode Patents for High Energy Lithium-ion Batteries
Solidion files multiple patent applications on a new process to produce graphene ball-hosted silicon anode materials DALLAS, Feb. 11, 2025 /PRNewswire/ -- Solidion Technology, Inc. (NASDAQ: STI), an advanced battery technology solutions provider,...
Axcelis Announces Participation in SEMICON Korea 2025
Learn About the Latest Products and Upgrades that Accelerate Intelligent Solutions in Ion Implant BEVERLY, Mass., Feb. 10, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for...
Elliott Statement on Aspen Technology, Inc.
WEST PALM BEACH, Fla., Feb. 7, 2025 /PRNewswire/ -- Elliott Investment Management L.P. ("Elliott"), which manages funds that together have an investment of more than $1.5 billion in Aspen Technology, Inc. (NASDAQ: AZPN) (the "Company" or...
NetEase to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 20
HANGZHOU, China, Feb. 6, 2025 /PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, "NetEase" or the "Company"), a leading internet and game services provider, today announced that it will report financial results for the fourth quarter and...
Youdao to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 20
HANGZHOU, China, Feb. 6, 2025 /PRNewswire/ -- Youdao, Inc. ("Youdao" or the "Company") (NYSE: DAO), an intelligent learning company with industry-leading technology in China, today announced that it will report its fourth quarter and fiscal year...
Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Serplulimab is the world's first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC Serplulimab is the first and only anti-PD-1 mAb approved in the European Union (EU) for the treatment of ES-SCLC Serplulimab has now...
I Peace establishes and offers low immunoreaction risk GMP iPS Cells
Three lines of GMP iPS Cells derived from type O female blood are now offered as off-the-shelf product PALO ALTO, Calif., Feb. 5, 2025 /PRNewswire/ -- Leading GMP cell CDMO I Peace, Inc. (https://ipeace.com/en/), specializing in induced pluripotent...
ReTo Announces Receipt of Nasdaq Delisting Determination and Plan to Appeal
BEIJING, Feb. 5, 2025 /PRNewswire/ -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) ("ReTo" or the "Company"), a manufacturer of equipment for production of eco-friendly materials in China, today announced that the Company received a delisting...
LabConnect Announces Formation of Strategic Advisory Board and Appointment of Inaugural Members
JOHNSON CITY, Tenn., Feb. 4, 2025 /PRNewswire/ -- LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the formation of its Strategic Advisory Board and the appointment of its...